CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

计划入组 9 人 · 首次发布于 2026 年 2 月 23 日

CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

计划入组 30 人 · 首次发布于 2025 年 2 月 10 日

CLL-1 CAR-NK Cells for Relapsed/Refractory AML

计划入组 24 人 · 首次发布于 2024 年 3 月 12 日

CAR NK-cell therapy

NKG2D-ACE2 CAR-NK Cell

OI-204

Senti Biosciences, Inc.

United States

Caribou Biosciences

United States

NKGEN BIOTECH

United States

CRISPR Gene Editing Advances CAR-NK Cell Therapy to Overcome Clinical Bottlenecks

Enhanced CAR-NK Cell Therapy Shows Superior Tumor Control Through Novel Costimulatory Design

First-in-Human iPSC-CAR-NK Cell Therapy Shows Promise for Autoimmune Disease Treatment